Patients with sporadic or familial pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis (PVOD/PCH) may be subjected to screening for eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4) mutations. This evidence concerns the gene EIF2AK4 and Pulmonary capillary hemangiomatosis.